Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 1,490.00
+135.00 (9.96%)
Aug 26, 2026, 12:57 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 88.78 billion as of August 25, 2026. Its market cap has increased by 289.38% in one year.
Market Cap
88.78B
Enterprise Value
87.09B
Revenue
28.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,490.00
ChartMarket Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 88.78B, an increase of 1,497.88%. That is a compound annual growth rate of 207.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 88.78B | 342.54% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 164.09B |
| Lin BioScience | 77.77B |
| CHO Pharma | 25.68B |
| Oneness Biotech | 22.51B |
| Sunmax Biotechnology | 21.73B |
| Medigen Vaccine Biologics | 18.51B |
| TaiMed Biologics | 17.43B |
| Ever Supreme Bio Technology | 15.88B |